CONFIDENTIAL Execution CopyConfidential Execution • May 8th, 2017 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations • New York
[**] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission.
COMMERCIAL AGREEMENT BY AND AMONG ALLERGAN USA, INC., Ironwood Pharmaceuticals, Inc. AND Forest Laboratories, LLCCommercial Agreement • May 8th, 2017 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations • New York
This COMMERCIAL AGREEMENT (this “Agreement”), is made and dated as of January 31, 2017 (the “Effective Date”), by and among Allergan USA, Inc., a corporation duly organized and existing under the Applicable Laws of the State of Delaware, and having a principal place of business at Morris Corporate Center III, 400 Interpace Parkway, Parsippany, New Jersey 07054 (“Allergan”), Ironwood Pharmaceuticals, Inc., a corporation duly organized and existing under the Applicable Laws of the State of Delaware, and having a principal place of business at 301 Binney Street, Cambridge, Massachusetts 02142 (“Ironwood”), and, for purposes of Section 3.1, Forest Laboratories, LLC (as successor-in-interest to Forest Laboratories, Inc.), a limited liability company duly organized and existing under the Applicable Laws of the State of Delaware, and having a principal place of business at Morris Corporate Center III, 400 Interpace Parkway, Parsippany, New Jersey 07054 (“Forest”). Allergan and Ironwood are so
TWELFTH AMENDMENT TO LEASELease • May 8th, 2017 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations
THIS TWELFTH AMENDMENT TO LEASE (this “Amendment”) is entered into as of this 30th day of March, 2017 (the “Execution Date”), by and between BMR-ROGERS STREET LLC, a Delaware limited liability company (“Landlord,” as successor-in-interest to Rogers Street, LLC (“Original Landlord”)), and IRONWOOD PHARMACEUTICALS, INC., a Delaware corporation (“Tenant,” formerly known as Microbia, Inc.).
